Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MPO | P05164 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.51 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8326406 | 0.96 | CHRM2 (0.66) | CHRM2L3MBTL1LMNASMN1; SMN2MPO | |
| SCHEMBL8019471 | 0.91 | CHRM2 (0.82) | CHRM2L3MBTL1SMN1; SMN2MPOALDH1A1 | |
| SCHEMBL1625535 | 0.89 | SMN1; SMN2 (0.64) | CHRM2SMN1; SMN2ALDH1A1KDM4EPDCD1 | |
| SCHEMBL4262728 | 0.88 | CHRM2 (0.71) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| Hydrochloric Acid SCHEMBL9672905 | 0.86 | CHRM2 (0.69) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| SCHEMBL8328507 | 0.86 | CHRM2 (0.75) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| SCHEMBL8328363 | 0.84 | CHRM2 (0.79) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| SCHEMBL26139696 | 0.82 | DPP7 (0.61) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| SCHEMBL8330901 | 0.81 | CHRM2 (0.53) | CHRM2L3MBTL1LMNAMPOALDH1A1 | |
| SCHEMBL1796909 | 0.81 | LMNA (0.77) | CHRM2L3MBTL1LMNAMPOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108341788-A | A kind of mosapride citrate intermediate and purposes | 鲁南制药集团股份有限公司 | 2018-07-31 | — | — | CN | claimed |
| CN-108129414-A | A kind of preparation method of mosapride citrate intermediate | 鲁南制药集团股份有限公司 | 2018-06-08 | — | — | CN | claimed |
| US-11802135-B2 | Lysophosphatidic acid derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-20230146210-A1 | NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-112225708-B | Preparation method of mosapride intermediate | 上海翰森生物医药科技有限公司 | 2021-04-09 | — | — | CN | disclosed |
| CN-112225708-A | Preparation method of mosapride intermediate | 上海翰森生物医药科技有限公司 | 2021-01-15 | — | — | CN | disclosed |
| CN-108129414-B | Preparation method of mosapride citrate intermediate | 鲁南制药集团股份有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-108341788-A | A kind of mosapride citrate intermediate and purposes | 鲁南制药集团股份有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-108129414-A | A kind of preparation method of mosapride citrate intermediate | 鲁南制药集团股份有限公司 | 2018-06-08 | — | — | CN | disclosed |
| EP-2928890-B1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2018-02-28 | — | — | EP | disclosed |
| EP-2804868-B1 | PYRAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS | VERTEX PHARMA (US) | 2017-04-12 | — | — | EP | disclosed |
| US-20050227959-A1 | Heterocyclic compound having oxime group | EISAI CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1515958-A2 | PROCESS FOR THE SYNTHESIS OF MOSAPRIDE | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 2005-03-23 | — | — | EP | disclosed |
| WO-2003106440-A2 | PROCESS FOR THE SYNTHESIS OF A BENZAMIDE DERIVATIVE | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 2003-12-24 | — | — | WO | disclosed |
| EP-0760368-B1 | PYRIMIDINE DERIVATIVES | NISSHIN FLOUR MILLING CO (JP) | 1999-07-28 | — | — | EP | disclosed |
| US-5736550-A | TREATMENT OF GASTROINTESTINAL TRACT DISORDERS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1998-04-07 | — | — | US | disclosed |
| EP-0760368-A1 | NOVEL PYRIMIDINE DERIVATIVE | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-03-05 | — | — | EP | disclosed |
| EP-0243959-B1 | SUBSTITUTED BENZAMIDE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Dainippon Pharmaceutical Co., Ltd. (JP) | 1992-08-19 | — | — | EP | disclosed |
| US-4870074-A | Substituted benzamide derivatives, for enhancing gastrointestinal motility | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1989-09-26 | — | — | US | disclosed |
| EP-0243959-A1 | Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | Dainippon Pharmaceutical Co., Ltd. (JP) | 1987-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802135-B2 | Lysophosphatidic acid derivative | LPAR4, LPAR2, LPAR1 | CHRM2 2132/4885L3MBTL1 1690/4885LMNA 1148/4885 |
| US-20050227959-A1 | Heterocyclic compound having oxime group | STAT6, HRH4, HRH2 | CHRM2 31/4885L3MBTL1 1685/4885LMNA 4744/4885 |
| US-20230146210-A1 | NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE | LPAR4, LPAR2, LPAR1 | CHRM2 1854/4885L3MBTL1 1923/4885LMNA 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.